Home › MannKind shares rise 10% after insulin drug Afrezza OKd by FDA
 

Keywords :   


MannKind shares rise 10% after insulin drug Afrezza OKd by FDA

2014-07-01 05:02:03| Biotech - Topix.net

Afrezza is a powder insulin that is inhaled through a handheld device. A quick puff would replace an insulin injection that patients with diabetes now use to regulate blood glucose levels.

Tags: by drug rise shares

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.11NI rise hits workers harder than employers, says OBR
05.11Tropical Storm Rafael Graphics
05.11Tropical Storm Rafael Wind Speed Probabilities Number 8
05.11Tropical Storm Rafael Public Advisory Number 8
05.11Summary for Tropical Storm Rafael (AT3/AL182024)
05.11Tropical Storm Rafael Forecast Advisory Number 8
05.11Lenzing Expands Nonwovens Range
05.11Netflix Europe offices raided in tax fraud probe
More »